539 related articles for article (PubMed ID: 25732147)
1. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
[TBL] [Abstract][Full Text] [Related]
2. The impact of endurance training and table soccer on brain metabolites in schizophrenia.
Rauchmann BS; Ghaseminejad F; Keeser D; Keller-Varady K; Schneider-Axmann T; Takahashi S; Karali T; Helms G; Dechent P; Maurus I; Hasan A; Wobrock T; Ertl-Wagner B; Schmitt A; Malchow B; Falkai P
Brain Imaging Behav; 2020 Apr; 14(2):515-526. PubMed ID: 31686308
[TBL] [Abstract][Full Text] [Related]
3. The relationship between oxidative stress markers and 1H-Magnetic resonance spectroscopy findings in obsessive compulsive disorder.
Subaşı Turgut F; Bulut M; Hattapoğlu S; Güneş M; Cemal Kaya M; Ekici F; Guli Çetinçakmak M; Kaplan İ; Atmaca M
Brain Res; 2024 Jun; 1833():148852. PubMed ID: 38494099
[TBL] [Abstract][Full Text] [Related]
4. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.
Ohrmann P; Kugel H; Bauer J; Siegmund A; Kölkebeck K; Suslow T; Wiedl KH; Rothermundt M; Arolt V; Pedersen A
Schizophr Res; 2008 Dec; 106(2-3):156-63. PubMed ID: 18799290
[TBL] [Abstract][Full Text] [Related]
5. Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.
Hutcheson NL; Reid MA; White DM; Kraguljac NV; Avsar KB; Bolding MS; Knowlton RC; den Hollander JA; Lahti AC
Schizophr Res; 2012 Sep; 140(1-3):136-42. PubMed ID: 22831772
[TBL] [Abstract][Full Text] [Related]
6. Effect of Bilateral Prefrontal rTMS on Left Prefrontal NAA and Glx Levels in Schizophrenia Patients with Predominant Negative Symptoms: An Exploratory Study.
Dlabac-de Lange JJ; Liemburg EJ; Bais L; van de Poel-Mustafayeva AT; de Lange-de Klerk ESM; Knegtering H; Aleman A
Brain Stimul; 2017; 10(1):59-64. PubMed ID: 27615793
[TBL] [Abstract][Full Text] [Related]
7. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.
Onwordi EC; Whitehurst T; Mansur A; Statton B; Berry A; Quinlan M; O'Regan DP; Rogdaki M; Marques TR; Rabiner EA; Gunn RN; Vernon AC; Natesan S; Howes OD
Transl Psychiatry; 2021 Jul; 11(1):393. PubMed ID: 34282130
[TBL] [Abstract][Full Text] [Related]
8. Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with schizophrenia: A
Ćurčić-Blake B; Bais L; Sibeijn-Kuiper A; Pijnenborg HM; Knegtering H; Liemburg E; Aleman A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():132-139. PubMed ID: 28546056
[TBL] [Abstract][Full Text] [Related]
9. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
[TBL] [Abstract][Full Text] [Related]
10. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
Burger A; Brooks SJ; Stein DJ; Howells FM
Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
[TBL] [Abstract][Full Text] [Related]
11. Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: a two-dimensional proton magnetic resonance spectroscopy study.
Li H; Xu H; Zhang Y; Guan J; Zhang J; Xu C; Shen Z; Xiao B; Liang C; Chen K; Zhang J; Wu R
Bipolar Disord; 2016 Nov; 18(7):583-590. PubMed ID: 27870506
[TBL] [Abstract][Full Text] [Related]
12. Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.
White TL; Monnig MA; Walsh EG; Nitenson AZ; Harris AD; Cohen RA; Porges EC; Woods AJ; Lamb DG; Boyd CA; Fekir S
Neuropsychopharmacology; 2018 Jun; 43(7):1498-1509. PubMed ID: 29511334
[TBL] [Abstract][Full Text] [Related]
13. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
14. Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia.
Kraguljac NV; Reid MA; White DM; den Hollander J; Lahti AC
Neuropsychopharmacology; 2012 Nov; 37(12):2635-42. PubMed ID: 22805603
[TBL] [Abstract][Full Text] [Related]
15. In vivo measurements of glutamine + glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy.
Savic I; Thomas AM; Ke Y; Curran J; Fried I; Engel J
Acta Neurol Scand; 2000 Sep; 102(3):179-88. PubMed ID: 10987378
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition.
Ohrmann P; Kersting A; Suslow T; Lalee-Mentzel J; Donges US; Fiebich M; Arolt V; Heindel W; Pfleiderer B
Neuroreport; 2004 Mar; 15(3):549-53. PubMed ID: 15094521
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
[TBL] [Abstract][Full Text] [Related]
18. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Spitzberg K; Kersting A; Arolt V; Heindel W; Pfleiderer B
Schizophr Res; 2005 Mar; 73(2-3):153-7. PubMed ID: 15653258
[TBL] [Abstract][Full Text] [Related]
19. Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.
Reid MA; Stoeckel LE; White DM; Avsar KB; Bolding MS; Akella NS; Knowlton RC; den Hollander JA; Lahti AC
Biol Psychiatry; 2010 Oct; 68(7):625-33. PubMed ID: 20570244
[TBL] [Abstract][Full Text] [Related]
20. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
